Biomarker studies increasingly utilize biofluids as an attractive source of molecules reflecting human health and disease states. Referred to as liquid biopsies, they have the advantage over tissue ...

In a letter to phlebotomists and laboratory directors, the FDA urged clinicians to stretch the time between tests whenever possible. (Getty Images) () The FDA is recommending that healthcare providers ...

Liquid biopsies have emerged as a powerful tool in modern medicine, enabling non-invasive detection and monitoring of diseases such as cancer. At the forefront of this revolution are the BD PAXgene ® ...